Maxwell Mumbach is a Founding Scientist and leads the Discovery team at Cartography Biosciences. He and the discovery team focus on multi-omic profiling of patient samples and validation of surface antigens on primary tissue. Prior to joining Cartography, he was a functional genomics scientist at Verily Life Sciences. Max received his training at the Broad Institute and then at Stanford University where he completed his graduate studies in Genetics. In his spare time, he enjoys chasing after his two year old son at the beach or park.
Recent Posts
- Cartography Announces Appointment of Troy Wilson, Ph.D., J.D., to its Board of Directors
- Cartography Announces Strategic Collaboration with Gilead to Develop Oncology Therapies Against Novel Targets and Target Pairs
- Cartography Biosciences Expands Leadership Team with Appointment of Dan Rock, Ph.D., as Chief Scientific Officer to Advance Novel Oncology Programs into Clinic
- Cartography Biosciences and Nested Therapeutics: Diamonds in the rough
- Cartography Biosciences Expands Scientific Advisory Board with Leading Antibody and Bi-specific Experts
Recent Comments
No comments to show.